WCG IPO Presentation Deck

Profile of Segment Financial Performance 16 Ethical Review $239mm of Revenue 80% + Gross Margin Technology-Enabled IRB Regulatory Services Based on Fixed Fee FY 2020 Financial Results Clinical Trial Solutions $224mm of Revenue 45% + Gross Margin Technology-Enabled Specialty Solutions Based on Professional Clinical Services Fees DNL wcg

View entire presentation